Centenial Surgical Suture (BSE 531380)₹72.66+3.50%Medical Equipment & Supplies
In the Mar 2026 quarter (standalone), Centenial Surgical Suture reported sales of ₹12.60 Cr, down 5.5% from Mar 2025, and net profit of −₹2.32 Cr. For the year to Mar 2026, sales were ₹53.95 Cr and net profit −₹2.21 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.68 | 13.13 | 12.40 | 12.08 | 13.77 | 14.29 | 12.23 | 13.34 | 12.96 | 13.49 | 14.89 | 12.60 |
| Expenses | 12.52 | 11.98 | 11.21 | 10.56 | 12.04 | 12.56 | 11.46 | 11.26 | 11.72 | 12.08 | 13.36 | 11.67 |
| Operating Profit | 1.17 | 1.15 | 1.20 | 1.52 | 1.73 | 1.74 | 0.76 | 2.07 | 1.24 | 1.40 | 1.54 | 0.94 |
| OPM % | 8.4% | 8.6% | 9.6% | 12.5% | 12.4% | 12.1% | 6.1% | 15.4% | 9.5% | 10.3% | 10.2% | 7.4% |
| Other Income | 0.02 | 0.03 | 0.07 | 0.04 | 0.00 | 0.07 | 0.02 | 0.06 | 0.00 | 0.06 | 0.06 | 0.08 |
| Interest | 0.49 | 0.53 | 0.52 | 0.96 | 0.54 | 0.54 | 0.51 | 2.20 | 0.33 | 0.47 | 0.36 | 2.22 |
| Depreciation | 0.29 | 0.31 | 0.32 | 0.43 | 0.78 | 1.08 | 1.10 | 1.25 | 0.94 | 0.98 | 1.03 | 1.01 |
| Profit before tax | 0.38 | 0.31 | 0.40 | 0.14 | 0.39 | 0.16 | −0.84 | −1.33 | −0.03 | 0.00 | 0.18 | −2.22 |
| Tax % | 25.7% | 28.2% | 24.5% | −26.6% | 25.1% | 23.6% | 0.0% | −11.1% | 0.0% | 0.0% | 26.4% | 4.1% |
| Net Profit | 0.30 | 0.25 | 0.32 | 0.20 | 0.31 | 0.14 | −0.86 | −1.19 | −0.05 | −0.02 | 0.16 | −2.32 |
| EPS (Rs) | 0.80 | 0.67 | 0.86 | 0.53 | 0.83 | 0.37 | −2.34 | −3.24 | −0.12 | −0.04 | 0.42 | −6.35 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.51 | 52.98 | 52.85 | 56.14 | 55.75 | 37.01 | 44.54 | 52.80 | 51.31 | 53.62 | 53.95 | 53.94 |
| Expenses | 46.75 | 47.99 | 48.34 | 50.69 | 49.78 | 31.89 | 40.01 | 48.35 | 46.12 | 47.12 | 48.83 | 48.83 |
| Operating Profit | 4.69 | 4.90 | 4.48 | 5.42 | 5.94 | 5.12 | 4.50 | 4.41 | 5.16 | 6.43 | 5.10 | 5.12 |
| OPM % | 9.1% | 9.2% | 8.4% | 9.6% | 10.6% | 13.7% | 10.0% | 8.3% | 10.0% | 11.9% | 9.4% | 9.5% |
| Other Income | 0.03 | 0.02 | 0.06 | 0.03 | 0.10 | 0.10 | 0.05 | 0.14 | 0.14 | 0.13 | 0.18 | 0.20 |
| Interest | 1.66 | 1.78 | 1.52 | 1.90 | 2.32 | 2.13 | 1.94 | 1.78 | 2.63 | 3.91 | 3.35 | 3.38 |
| Depreciation | 0.67 | 0.58 | 0.59 | 0.68 | 1.54 | 1.54 | 1.52 | 1.29 | 1.38 | 4.24 | 3.99 | 3.96 |
| Profit before tax | 2.36 | 2.53 | 2.40 | 2.84 | 2.15 | 1.52 | 1.06 | 1.45 | 1.26 | −1.60 | −2.07 | −2.07 |
| Tax % | 34.2% | 32.8% | 36.2% | 29.2% | 39.9% | 37.3% | 42.2% | 39.8% | 11.1% | −9.3% | 6.3% | — |
| Net Profit | 1.57 | 1.73 | 1.55 | 2.03 | 1.31 | 0.97 | 0.64 | 0.90 | 1.14 | −1.47 | −2.21 | −2.23 |
| EPS (Rs) | 4.29 | 4.73 | 4.23 | 5.56 | 3.57 | 2.64 | 1.74 | 2.45 | 3.11 | −4.01 | −6.05 | −6.09 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.43 | 5.44 | 5.43 | 5.43 | 5.44 | 5.44 | 5.43 | 5.43 | 5.43 | 5.43 | 5.44 | 5.44 |
| Reserves | 15.80 | 17.36 | 19.08 | 20.65 | 22.67 | 23.21 | 24.18 | 24.80 | 25.70 | 26.85 | 25.38 | 23.17 |
| Borrowings | 12.26 | 13.08 | 15.21 | 14.33 | 13.06 | 12.70 | 13.43 | 9.29 | 9.89 | 23.18 | 29.94 | 10.68 |
| Other Liabilities | 21.76 | 16.64 | 16.05 | 14.90 | 15.58 | 27.89 | 26.94 | 21.79 | 25.31 | 23.67 | 23.77 | 40.43 |
| Total Liabilities | 55.25 | 52.52 | 55.77 | 55.31 | 56.75 | 69.24 | 69.98 | 61.31 | 66.33 | 79.13 | 84.53 | 79.72 |
| Fixed Assets | 4.11 | 3.63 | 3.70 | 3.79 | 4.07 | 10.41 | 8.94 | 7.58 | 6.44 | 12.73 | 19.95 | 18.17 |
| CWIP | 0.20 | 0.20 | 0.20 | 0.23 | 0.23 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 50.94 | 48.69 | 51.87 | 51.29 | 52.45 | 58.60 | 61.04 | 53.73 | 59.89 | 66.40 | 64.58 | 61.55 |
| Inventories | 22.21 | 23.44 | 29.55 | 30.49 | 29.74 | 32.09 | 36.12 | 32.14 | 37.15 | 42.39 | 43.36 | 40.54 |
| Trade receivables | 19.66 | 18.75 | 19.01 | 18.18 | 20.77 | 23.43 | 22.47 | 19.62 | 20.67 | 18.87 | 18.48 | 18.36 |
| Cash & equivalents | 1.95 | 1.07 | 0.82 | 1.06 | 0.32 | 0.71 | 0.53 | 0.25 | 0.32 | 0.67 | 0.21 | 0.19 |
| Total Assets | 55.25 | 52.52 | 55.77 | 55.31 | 56.75 | 69.24 | 69.98 | 61.31 | 66.33 | 79.13 | 84.53 | 79.72 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.22 | −1.52 | 0.00 | 1.77 | 1.56 | 2.09 | 1.98 | 4.77 | 1.31 | 6.23 | 17.13 | 7.31 |
| Cash from investing activity | −0.37 | −0.20 | −2.39 | −0.65 | −1.03 | −1.32 | −0.90 | −0.18 | −0.19 | −7.95 | −11.66 | −2.42 |
| Cash from financing activity | 0.95 | 0.81 | 2.13 | −0.87 | −1.26 | −0.36 | −1.26 | −4.85 | −1.04 | 2.05 | −5.91 | −4.88 |
| Net cash flow | 0.81 | −0.89 | −0.26 | 0.25 | −0.76 | 0.41 | −0.19 | −0.29 | 0.08 | 0.36 | −0.48 | −0.03 |
| Capex | 0.39 | 0.21 | 0.67 | 0.72 | 0.99 | 1.09 | 0.85 | 0.17 | 0.17 | 7.72 | 11.50 | 2.24 |
| Free cash flow | −0.16 | −1.71 | −0.67 | 1.06 | 0.58 | 1.01 | 1.14 | 4.60 | 1.15 | −1.50 | 5.62 | 5.07 |
| CFO / OP % | 23.1% | −14.9% | 0.0% | 59.1% | 44.1% | 50.1% | 50.1% | 112.1% | 42.1% | 129.1% | 270.1% | 144.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 139 | 134 | 132 | 126 | 136 | 154 | 222 | 161 | 144 | 135 | 127 | 125 |
| Inventory days | 349 | 365 | 468 | 465 | 434 | 483 | 1,275 | 598 | 676 | 909 | 921 | 790 |
| Days payable | 168 | 125 | 147 | 137 | 121 | 189 | 374 | 160 | 223 | 209 | 153 | 147 |
| Cash conversion cycle | 322 | 375 | 454 | 457 | 450 | 450 | 1,126 | 602 | 599 | 837 | 896 | 771 |
| Working capital days | 127 | 149 | 156 | 164 | 168 | 172 | 282 | 237 | 208 | 227 | 211 | 192 |
| ROCE % | 14.1% | 11.6% | 11.4% | 9.8% | 11.6% | 10.8% | 8.6% | 7.3% | 8.0% | 8.1% | 3.9% | 2.5% |
For the Mar 2026 quarter, Centenial Surgical Suture reported sales of ₹12.60 Cr, down 5.5% year on year and net profit of −₹2.32 Cr. The operating margin was 7.4%.
Centenial Surgical Suture's sales for the year to Mar 2026 were ₹53.95 Cr; over the last twelve months they were ₹53.94 Cr.
Net profit for the year to Mar 2026 was −₹2.21 Cr, and −₹2.23 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−6.09.
Centenial Surgical Suture reported borrowings of ₹10.68 Cr at Mar 2026, against cash and equivalents of ₹0.19 Cr.
Cash from operations was ₹7.31 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.07 Cr.